AU586839B2 - Substituted imidazole derivatives and their preparation and use - Google Patents
Substituted imidazole derivatives and their preparation and useInfo
- Publication number
- AU586839B2 AU586839B2 AU50083/85A AU5008385A AU586839B2 AU 586839 B2 AU586839 B2 AU 586839B2 AU 50083/85 A AU50083/85 A AU 50083/85A AU 5008385 A AU5008385 A AU 5008385A AU 586839 B2 AU586839 B2 AU 586839B2
- Authority
- AU
- Australia
- Prior art keywords
- och3
- preparation
- ch2ch3
- hal
- imidazole derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 R4 is H Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Lubricants (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Resins (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Dental Preparations (AREA)
- Golf Clubs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08429578A GB2167408B (en) | 1984-11-23 | 1984-11-23 | Substituted imidazole derivatives and their preparation and use |
| GB8429578 | 1984-11-23 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33329/89A Division AU3332989A (en) | 1984-11-23 | 1989-04-21 | Substituted imidazole derivatives and their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5008385A AU5008385A (en) | 1986-05-29 |
| AU586839B2 true AU586839B2 (en) | 1989-07-27 |
Family
ID=10570140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU50083/85A Expired AU586839B2 (en) | 1984-11-23 | 1985-11-20 | Substituted imidazole derivatives and their preparation and use |
| AU33329/89A Abandoned AU3332989A (en) | 1984-11-23 | 1989-04-21 | Substituted imidazole derivatives and their preparation and use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33329/89A Abandoned AU3332989A (en) | 1984-11-23 | 1989-04-21 | Substituted imidazole derivatives and their preparation and use |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4689339A (OSRAM) |
| EP (2) | EP0183492B1 (OSRAM) |
| JP (1) | JPH064597B2 (OSRAM) |
| KR (1) | KR930004673B1 (OSRAM) |
| AT (2) | ATE85050T1 (OSRAM) |
| AU (2) | AU586839B2 (OSRAM) |
| BG (1) | BG60762B2 (OSRAM) |
| CA (1) | CA1268770C (OSRAM) |
| DD (1) | DD258230A1 (OSRAM) |
| DE (2) | DE3587045T2 (OSRAM) |
| DK (2) | DK164903C (OSRAM) |
| ES (2) | ES8704462A1 (OSRAM) |
| FI (1) | FI80264C (OSRAM) |
| GB (1) | GB2167408B (OSRAM) |
| GR (1) | GR852817B (OSRAM) |
| HK (1) | HK3592A (OSRAM) |
| HU (1) | HU195189B (OSRAM) |
| IE (1) | IE58165B1 (OSRAM) |
| IL (1) | IL77111A (OSRAM) |
| NO (1) | NO166585C (OSRAM) |
| NZ (1) | NZ214258A (OSRAM) |
| PH (1) | PH22016A (OSRAM) |
| PT (1) | PT81542B (OSRAM) |
| SG (1) | SG106891G (OSRAM) |
| SU (1) | SU1424736A3 (OSRAM) |
| ZA (1) | ZA858942B (OSRAM) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU600725B2 (en) * | 1986-05-15 | 1990-08-23 | Orion-Yhtyma Oy | 4(5)-substituted imidazole derivatives, and intermediates and processes for their preparation |
| AU634556B2 (en) * | 1986-05-15 | 1993-02-25 | Orion-Yhtyma Oy | 4(5)-substituted imidazole derivatives, and intermediates and processes for their preparation |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0252162A4 (en) * | 1986-01-28 | 1988-07-29 | Mitsui Petrochemical Ind | PROCESS FOR THE PREPARATION OF NON-SUBSTITUTED 2-IMIDAZOLES. |
| JP2576493B2 (ja) * | 1987-03-20 | 1997-01-29 | アイシン精機株式会社 | 原稿読取り装置に用いられる原稿トレ− |
| FR2621327B1 (fr) * | 1987-10-06 | 1990-01-05 | Commissariat Energie Atomique | Procede de production et d'extraction de polysaccharides a partir d'une culture de porphyridium cruentum et dispositif pour la mise en oeuvre du procede |
| GB2225782A (en) * | 1988-12-09 | 1990-06-13 | Farmos Group Limited | Imidazole derivatives useful for treatment of diabetes |
| GB8903437D0 (en) * | 1989-02-15 | 1989-04-05 | Erba Carlo Spa | Imidazolyl derivatives of 3,4-dihydro-2h-1-benzothiopyran |
| CA1321751C (en) * | 1989-02-21 | 1993-08-31 | Eugene C. Crichlow | Mechanism mediating ruminal stasis in ruminal lactic acidosis |
| DK344489D0 (da) * | 1989-07-12 | 1989-07-12 | Novo Nordisk As | Substituerede 2-imidazoliner og fremstilling og anvendelse deraf |
| GB2244431A (en) * | 1990-05-31 | 1991-12-04 | Farmos Oy | Treatment of age related memory impairment and other cognitive disorders |
| GB2256135B (en) | 1991-05-31 | 1995-01-18 | Orion Yhtymae Oy | Transdermal administration of 4-substituted imidazoles |
| US5541211A (en) * | 1991-06-18 | 1996-07-30 | Orion-Yhtyma Oy | Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission |
| ES2164054T3 (es) * | 1991-11-05 | 2002-02-16 | Smithkline Beecham Corp | Antagonistas de receptores de endotelina. |
| GB9127050D0 (en) * | 1991-12-20 | 1992-02-19 | Orion Yhtymae Oy | Substituted imidazole derivatives and their preparation and use |
| GB9127430D0 (en) * | 1991-12-27 | 1992-02-19 | Scras | Benzofuranylimidazole derivatives |
| GB9312669D0 (en) * | 1993-06-18 | 1993-08-04 | Orion Yhtymae Oy | New opticla isomers |
| GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
| FR2733983B1 (fr) * | 1995-05-10 | 1997-08-01 | Pf Medicament | Procede de preparation d'un derive d'acide benzofurane carboxylque optiquement pur et son utilisation pour preparer l'efaroxan |
| GB9520150D0 (en) * | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
| WO1998055439A1 (en) * | 1997-06-05 | 1998-12-10 | Venantius Limited | Indane compounds and their pharmaceutical use |
| WO1999051593A1 (en) * | 1998-04-02 | 1999-10-14 | Ortho-Mcneil Pharmaceutical, Inc. | 4-thionaphthyl-1h-imidazoles with alpha-2-adrenergic activity |
| FR2784989B1 (fr) * | 1998-09-10 | 2002-09-27 | Fabre Pierre Sante | Derive d'ester d'acide 2-ethyl-2,3-dihydrobenzofurane- carboxylique, procede de preparation et utilisation pour la preparation de derives de l'efaroxan |
| WO2000042023A1 (en) * | 1999-01-18 | 2000-07-20 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
| US6388090B2 (en) | 2000-01-14 | 2002-05-14 | Orion Corporation | Imidazole derivatives |
| US6593324B2 (en) | 2000-03-01 | 2003-07-15 | Orion Corporation | Dervatives of quinoline as alpha-2 antagonists |
| ATE302757T1 (de) | 2000-05-08 | 2005-09-15 | Orion Corp | Neue polyzyklische indanylimidazole mit alpha2 adrenergik aktivität |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US6543389B2 (en) | 2001-06-26 | 2003-04-08 | Pfizer Inc. | Insecticidal pet collar |
| CA2480695A1 (en) | 2002-04-03 | 2003-10-09 | Orion Corporation | Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| US8188126B2 (en) | 2002-05-16 | 2012-05-29 | Pierre Fabre Medicament | Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| FI116292B (fi) * | 2003-01-08 | 2005-10-31 | Juvantia Pharma Ltd Oy | Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita |
| ES2315740T3 (es) * | 2003-11-04 | 2009-04-01 | Intervet International Bv | Formulaciones ectoparasiticidas de espinosinas y pesticidas de azol. |
| FI20050657A0 (fi) * | 2005-06-17 | 2005-06-17 | Orion Corp | Atipametsolin kiteytysmenetelmä |
| CA2624788C (en) | 2005-10-12 | 2011-04-19 | Unimed Pharmaceuticals, Llc | Improved testosterone gel and method of use |
| US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| WO2008017591A1 (en) * | 2006-08-08 | 2008-02-14 | Intervet International B.V. | Composition for enhanced antiparasitic activity |
| TWI457122B (zh) | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物 |
| CL2008003553A1 (es) * | 2007-12-05 | 2009-11-27 | Grindeks Jsc | Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso |
| CR20160214A (es) | 2013-11-05 | 2016-10-11 | 3M Innovative Properties Co | Formulaciones de inyección con base en aceite de sésamo |
| TWI704145B (zh) | 2015-06-05 | 2020-09-11 | 芬蘭商奧利安公司 | 新醫藥化合物 |
| EP3370718B1 (en) | 2015-11-05 | 2021-01-27 | University Of Louisville Research Foundation, Inc. | Local and regional anesthesia and analgesia |
| JP2019519582A (ja) | 2016-06-29 | 2019-07-11 | オリオン コーポレーション | ベンゾジオキサン誘導体およびその医薬用途 |
| CN113194750A (zh) | 2018-12-21 | 2021-07-30 | 雀巢产品有限公司 | 用于在婴儿或幼儿中引起饱腹感、更好的睡眠和/或限制夜间觉醒的营养组合物 |
| CN111978254A (zh) * | 2019-05-22 | 2020-11-24 | 南京康德祥医药科技有限公司 | 一种阿替美唑盐酸盐的制备工艺 |
| CN111925330A (zh) * | 2020-09-07 | 2020-11-13 | 上海阿达玛斯试剂有限公司 | 一种阿替美唑的制备方法 |
| EP4658639A1 (en) | 2023-02-01 | 2025-12-10 | Univerza V Ljubljani | N,n-dialkyl-4-(2-ethylindan-2-yl)-1h-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases |
| LU103072B1 (en) | 2023-02-15 | 2024-08-19 | Univ Ljubljani | N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-lH-IMIDAZOLE-l-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2933962A1 (de) * | 1979-08-22 | 1981-03-26 | Hoechst Ag, 65929 Frankfurt | Verfahren zur herstellung von 4,5-dichlor-imidazolen. |
| US4342775A (en) * | 1980-03-04 | 1982-08-03 | Farmitalia Carlo Erba S.P.A. | 3-(1-Imidazolyl)-derivatives of 2,3-dihydro-4H-1-benzopyran |
| US4302469A (en) * | 1980-09-10 | 1981-11-24 | Syntex (U.S.A.) Inc. | 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants |
| NZ201219A (en) * | 1981-07-28 | 1984-10-19 | Reckitt & Colmann Prod Ltd | Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions |
| ES8503669A1 (es) * | 1982-07-05 | 1985-03-01 | Erba Farmitalia | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. |
| FR2539415B1 (fr) * | 1983-01-14 | 1985-09-13 | Adir | Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique |
| FR2542738A1 (fr) * | 1983-03-18 | 1984-09-21 | Synthelabo | Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent |
-
1984
- 1984-11-23 GB GB08429578A patent/GB2167408B/en not_active Expired
-
1985
- 1985-11-05 FI FI854335A patent/FI80264C/fi not_active IP Right Cessation
- 1985-11-18 CA CA 495608 patent/CA1268770C/xx not_active Expired - Lifetime
- 1985-11-20 AU AU50083/85A patent/AU586839B2/en not_active Expired
- 1985-11-20 NZ NZ214258A patent/NZ214258A/xx unknown
- 1985-11-20 DD DD85283044A patent/DD258230A1/de not_active IP Right Cessation
- 1985-11-20 IL IL77111A patent/IL77111A/xx not_active IP Right Cessation
- 1985-11-21 AT AT88106210T patent/ATE85050T1/de not_active IP Right Cessation
- 1985-11-21 DE DE8888106210T patent/DE3587045T2/de not_active Expired - Fee Related
- 1985-11-21 ZA ZA858942A patent/ZA858942B/xx unknown
- 1985-11-21 PH PH33077A patent/PH22016A/en unknown
- 1985-11-21 KR KR1019850008704A patent/KR930004673B1/ko not_active Expired - Fee Related
- 1985-11-21 EP EP85308491A patent/EP0183492B1/en not_active Expired
- 1985-11-21 AT AT85308491T patent/ATE47997T1/de not_active IP Right Cessation
- 1985-11-21 GR GR852817A patent/GR852817B/el unknown
- 1985-11-21 US US06/800,192 patent/US4689339A/en not_active Expired - Lifetime
- 1985-11-21 EP EP88106210A patent/EP0310745B1/en not_active Expired - Lifetime
- 1985-11-21 IE IE292985A patent/IE58165B1/en not_active IP Right Cessation
- 1985-11-21 DE DE8585308491T patent/DE3574252D1/de not_active Expired
- 1985-11-22 ES ES549178A patent/ES8704462A1/es not_active Expired
- 1985-11-22 HU HU854471A patent/HU195189B/hu unknown
- 1985-11-22 NO NO854671A patent/NO166585C/no unknown
- 1985-11-22 SU SU853979907A patent/SU1424736A3/ru active
- 1985-11-22 DK DK540485A patent/DK164903C/da not_active IP Right Cessation
- 1985-11-22 PT PT81542A patent/PT81542B/pt unknown
- 1985-11-22 JP JP60263586A patent/JPH064597B2/ja not_active Expired - Lifetime
-
1986
- 1986-12-29 ES ES557268A patent/ES8801248A1/es not_active Expired
-
1989
- 1989-04-21 AU AU33329/89A patent/AU3332989A/en not_active Abandoned
-
1991
- 1991-12-17 SG SG1068/91A patent/SG106891G/en unknown
-
1992
- 1992-01-09 HK HK35/92A patent/HK3592A/en not_active IP Right Cessation
- 1992-05-04 DK DK058292A patent/DK58292A/da not_active Application Discontinuation
-
1994
- 1994-01-18 BG BG098378A patent/BG60762B2/bg unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU600725B2 (en) * | 1986-05-15 | 1990-08-23 | Orion-Yhtyma Oy | 4(5)-substituted imidazole derivatives, and intermediates and processes for their preparation |
| AU634556B2 (en) * | 1986-05-15 | 1993-02-25 | Orion-Yhtyma Oy | 4(5)-substituted imidazole derivatives, and intermediates and processes for their preparation |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU586839B2 (en) | Substituted imidazole derivatives and their preparation and use | |
| IL74031A0 (en) | Cyanoguanidinophenyldihydropyridazinone derivatives,their preparation and pharmaceutical compositions containing them | |
| IL77717A (en) | Pharmaceutical compositions containing derivatives of imidazole,their preparation and some novel compounds of this type | |
| FI871655A7 (fi) | Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat. | |
| AU1507888A (en) | New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same | |
| HUT52065A (en) | Process for producing substituted imidazol derivatives and pharmaceutical compositions containing them | |
| DK530685A (da) | 9-chlor-1,5-benzothiazepinderivater samt fremgangsmaade til fremstilling deraf | |
| DE3160719D1 (en) | Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them | |
| ZA838139B (en) | Semicarbazides,process for preparing these,and pharmaceutical compositions thereof | |
| MY101746A (en) | 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof. |